Argitalpenak (133) PATRICIA DE SEQUERA ORTIZ argitalpenak

2024

  1. Cardiovascular risk assessment: Missing albuminuria contributing to gender inequality

    Nefrologia

  2. Consensus on the approach to hydrosaline overload in acute heart failure. SEMI/SEC/S.E.N. recommendations

    Revista Espanola de Cardiologia, Vol. 77, Núm. 7, pp. 556-565

  3. Economic impact of the use of patiromer in chronic kidney disease or heart failure for the treatment of chronic hyperkalemia in Spain

    Nefrologia

  4. Enfermedad Renal Crónica

    Libro blanco salud y género (Estudio de comunicación), pp. 235-253

  5. Enhancing the management of chronic diseases in clinical practice: The CARABELA methodology

    Journal of Healthcare Quality Research, Vol. 39, Núm. 5, pp. 336-339

  6. Genetic Characterization of Kidney Failure of Unknown Etiology in Spain: Findings From the GENSEN Study

    American Journal of Kidney Diseases

  7. Genetic study in young patients with chronic kidney disease stage G5 from unknown etiology. The GENSEN study design

    Nefrologia, Vol. 44, Núm. 4, pp. 568-575

  8. Hacia la estandarización de la formación de PoCUS en nefrología: el momento es ahora

    Nefrologia, Vol. 44, Núm. 1, pp. 5-9

  9. Hyperaldosteronism and hyperparathyroidism: A disturbing friendship

    Nefrologia

  10. Impact of pruriture associated with chronic renal disease (PaCKD) on the quality of life of patients in hemodialysis in Spain

    Nefrologia

  11. Practical Approaches to the Management of Cardiorenal Disease beyond Congestion

    Cardiorenal medicine, Vol. 14, Núm. 1, pp. 235-250

2023

  1. Acute renal failure due to rhabdomyolysis in relation to abiraterone and rosuvastatin

    Nefrologia

  2. Clinical Characteristics and Management of Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis: A Feasibility Analysis of Electronic Health Records Using Natural Language Processing

    Kidney Diseases, Vol. 9, Núm. 3, pp. 187-196

  3. Economic impact of the use of patiromer in chronic kidney disease or heart failure for the treatment of chronic hyperkalemia in Spain

    Nefrologia, Vol. 43, Núm. 6, pp. 721-730

  4. Enfermedad renal crónica y su situación en España

    Eidon: revista de la fundación de ciencias de la salud, Núm. 60, pp. 127-199

  5. From cardiorenal syndromes to cardionephrology: a reflection by nephrologists on renocardiac syndromes

    Clinical Kidney Journal, Vol. 16, Núm. 1, pp. 19-29

  6. Humoral response after the fourth dose of the SARS-CoV-2 vaccine in the CKD spectrum: a prespecified analysis of the SENCOVAC study

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 38, Núm. 4, pp. 969-981

  7. Impact of pruriture associated with chronic renal disease (PaCKD) on the quality of life of patients in hemodialysis in Spain

    Nefrologia, Vol. 43, Núm. 6, pp. 663-667

  8. La enfermedad renal crónica, una epidemia silenciosa

    RIECS: Revista de Investigación y Educación en Ciencias de la Salud, Vol. 8, Núm. 2, pp. 3-10

  9. Lessons from SENCOVAC: A prospective study evaluating the response to SARS-CoV-2 vaccination in the CKD spectrum

    Nefrologia